Table 2.
Clinicopathologic characteristics of patients
| Patients (N = 32) | |
| Median age, years (range) | 61.5 (37–85) |
| Median BMI (range) | 30.5 (19–51) |
| Histology—postoperative diagnosis | 32 |
| Atypical hyperplasia/intraepithelial neoplasia | 2 |
| Endometrioid adenocarcinoma of the uterus | 14 |
| Grade 1, 2 | 8 |
| Grade 3 | 6 |
| Serous/clear cell carcinoma of the uterus | 9 |
| Low grade endometrial stromal sarcoma of the uterus | 1 |
| Myometrial invasion assessment in uterine carcinoma | |
| < 50% | 13 |
| > 50% | 10 |
| Cervical carcinoma | 6 |
| Squamous cell carcinoma | 4 |
| Adenocarcinoma | 2 |
| FIGO final stage | |
| Preinvasive disease (endometrial intraepithelial neoplasia) | 2 |
| Endometrial cancer | |
| IA | 13 |
| IB | 8 |
| IIIB | 1 |
| IIIC | 1 |
| Low-grade endometrial stromal sarcoma | |
| IA | 1 |
| Cervical cancer | |
| IB1 | 4 |
| IIA1 | 2 |